Mabpharm Limited

HKEX:2181.HK

0.305 (HKD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017
Revenue 87.16155.91882.882014.07423.9274.69
Cost of Revenue 11.92315.37516.7770000
Gross Profit 75.23840.54366.105014.07423.9274.69
Gross Profit Ratio 0.8630.7250.7980111
Reseach & Development Expenses 123.211147.906263.572120.418134.18988.98321.632
General & Administrative Expenses 21.01821.96921.29118.45690.47934.3654.867
Selling & Marketing Expenses 48.92528.2139.4230000
SG&A 69.94350.18230.71418.45690.47934.3654.867
Other Expenses -0.19241.66856.47724.56-14.0741.7260.326
Operating Expenses 273.523239.756350.763163.434210.594147.54342.475
Operating Income -199.693-203.83-289.268-180.69-194.834-148.112-44.378
Operating Income Ratio -2.291-3.645-3.490-13.844-6.19-9.462
Total Other Income Expenses Net -9.663-6.989-2.476-3.942-7.695-4.481-3.328
Income Before Tax -209.356-210.819-291.744-184.632-202.529-152.593-47.706
Income Before Tax Ratio -2.402-3.77-3.520-14.39-6.377-10.172
Income Tax Expense 60.527-0.1992.4763.9427.695-2.834-16.642
Net Income -209.356-210.62-294.22-188.574-210.224-124.883-31.064
Net Income Ratio -2.402-3.767-3.550-14.937-5.219-6.623
EPS -0.051-0.051-0.071-0.046-0.055-0.03-0.008
EPS Diluted -0.051-0.051-0.071-0.046-0.055-0.03-0.008
EBITDA -138.998-152.281-245.391-156.293-172.636-136.396-34.298
EBITDA Ratio -1.595-2.723-2.9610-12.266-5.701-7.313